Activity Overview
This educational activity is an archive of the live presentation held on April 11, 2026.
For more information about this educational activity, the faculty, and disclosures, please click here.
Target Audience
This educational activity is directed toward medical oncologists, surgical oncologists, radiation oncologists, gastroenterologists, and hepatologists who are interested in the treatment of gastrointestinal (GI) cancers. Nurse practitioners, physician assistants, nurses, pathologists, pharmacists, and other health care professionals involved in the treatment and management of patients with GI cancers are invited to attend.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Assess the clinical utility of novel molecular and genomic strategies for personalizing treatment decisions in patients with GI cancers
- Evaluate the clinical impact of recent findings from landmark trials of emerging treatment strategies for the management of GI cancers
- Apply evolving evidence into individualized, multidisciplinary care strategies to improve outcomes for patients with GI cancers
- Implement best practices for preventing, recognizing, and managing TRAEs associated with novel therapies used for the management of GI cancers
E. Gabriela Chiorean, MD
Professor of Medicine
University of Washington School of Medicine
Clinical Director, Gastrointestinal Oncology
Professor, Fred Hutchinson Cancer Center
Seattle, WA
Anthony El-Khoueiry, MD
Associate Director for Clinical Research
Chief, Section of Developmental Therapeutics/Phase I Program
Verna R. Richter Chair in Cancer Research
USC Norris Comprehensive Cancer Center
Los Angeles, CA
Full faculty information and disclosures are available by reviewing the program workbook, linked here.
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.